drugset / Trial / NCT05369104
Phage Therapy in Prosthetic Joint Infection Due to Staphylococcus Aureus Treated With DAIR.
RandomizedParallel-groupDouble-blindTreatment
Summary
Pilot non comparative study assessing the clinical control of infection of DAIR + SAT +NaCl and DAIR + SAT + Phages anti-Staphylococcus aureus in patients with Staphylococcus aureus Prosthetic Joint Infection with an indication of DAIR + SAT.
Timeline
- Start
- 2022-06-15
- Primary completion
- 2023-12-16
- Completion
- 2025-06-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PP1493 | Other / unclassified | 1 ml | Other |
| Subject | PP1815 | Other / unclassified | 1 ml | Other |